A breast cancer diagnosis or history doesn’t close the door on life insurance. Many survivors qualify for standard rates, and the earlier the stage at diagnosis, the more favorable your options are likely to be.
Breast cancer is one of the most common cancer histories underwriters review, and carriers have well-established guidelines for evaluating it. Here’s what to expect.
How underwriters evaluate breast cancer history
Underwriters look at a specific set of factors: the stage at diagnosis, the tumor’s hormone receptor status, the treatment received, and — most importantly — how much time has passed since treatment ended with no recurrence.
Two people with the same original diagnosis can have very different underwriting outcomes depending on how their cancer was staged and treated. A broker who regularly places breast cancer cases knows how to present your specific history in the way underwriters expect to see it.
Rates and eligibility by stage
Stage 0 (DCIS — ductal carcinoma in situ). Often treated similarly to a precancerous condition rather than invasive cancer. Standard or even preferred rates are achievable at most carriers after a one-to-two year disease-free period following treatment.
Stage I. Highly treatable with excellent long-term outcomes. Most carriers offer standard rates after a two-to-three year disease-free period, and some will consider preferred rates for very favorable cases with clean follow-up.
Stage II. Standard rates are typically achievable after a three-to-five year disease-free period, depending on tumor size, lymph node involvement, and hormone receptor status.
Stage III. Coverage is available but the carrier pool narrows. Most carriers want to see five or more years disease-free, and a table rating — a modest premium surcharge — is common.
Stage IV. Traditional coverage through standard carriers is generally not available. Guaranteed issue whole life insurance is the realistic path to coverage in this situation.
What helps your application
Hormone receptor status. Hormone receptor-positive (ER+/PR+) cancers, which respond to hormone therapy, are often viewed more favorably than triple-negative breast cancer, which has a higher recurrence profile in the years immediately following treatment.
Consistent follow-up care. Underwriters want to see documented mammograms and oncology check-ins on a regular schedule. A clean, consistent follow-up record is one of the strongest things you can bring to an application.
Hormone therapy compliance. If you were prescribed tamoxifen, an aromatase inhibitor, or similar hormone therapy, staying compliant with that treatment plan is viewed as a positive underwriting signal.
Genetic testing results. If you carry a BRCA1 or BRCA2 mutation, disclose it. Some carriers factor this into their evaluation, but it does not automatically disqualify you, especially if you’ve undergone preventive measures like enhanced screening or risk-reducing surgery.
What rates actually look like
A 50-year-old non-smoker with Stage I breast cancer, five years disease-free with clean follow-up, might qualify for standard rates at several carriers — a $500,000 20-year term policy in that scenario might run $90 to $130 per month depending on the carrier.
The same profile with a Stage III history and a five-year disease-free record might see a table-rated premium in the $180 to $260 per month range for identical coverage.
The spread between carriers on breast cancer cases can be significant. One carrier may offer standard rates on a Stage II case with strong follow-up; another may apply a much heavier rating for the exact same history. This is where an independent broker makes a measurable difference — matching your specific diagnosis and timeline to the carrier most likely to offer the best outcome.
A real placement from our book
Client — age 47, Las Vegas, NV. A client came to us four years after completing treatment for Stage II, hormone receptor-positive breast cancer — lumpectomy, radiation, and five years of tamoxifen, which she was still completing. She had been declined by one carrier and offered a heavily rated policy by another before coming to us.
We reviewed her full oncology record, including consistent mammogram follow-up and clean imaging at her most recent visit, and pre-screened her case with three carriers known for more favorable breast cancer underwriting. One approved her at a mild Table 2 rating rather than the heavier rating she’d been quoted elsewhere — $500,000 of 20-year term at $146 per month, compared to the $215 per month she’d been quoted by the other carrier. That’s a savings of $16,560 over the life of the policy for identical coverage.
What to do before you apply
Gather your treatment summary. Your oncologist can provide a summary documenting your original diagnosis, stage, treatment received, and current status. Having this ready speeds up underwriting significantly.
Stay current with follow-up screening. Consistent mammograms and oncology visits are one of the strongest signals of stability you can bring to an application.
Be transparent about your full history. Cancer history appears in medical records without exception. Disclosing it accurately and proactively is always the right approach — omissions can result in a denied claim later.
Work with a broker who places breast cancer cases regularly. Carrier guidelines vary enormously for this diagnosis. The right match can be the difference between a decline and an approval, or between a heavy rating and a mild one.
If you’re also working out how much coverage you need, our life insurance needs calculator is a good starting point.
Get your free quote today
At Term Insurance Brokers, breast cancer cases are part of what we handle every week. We represent more than 30 top-rated carriers and know exactly which ones take the most favorable view of your specific stage, treatment history, and time since diagnosis.
There’s no cost for a quote and no obligation. We do the carrier comparison — you make the decision.
Call us at 888-972-0024 or visit terminsurancebrokers.com for your free, no-obligation quote today.
Term Insurance Brokers is an independent brokerage licensed in 35+ states, based in Las Vegas, Nevada. We are not affiliated with any single insurance company.